Navigation Links
Thoratec Announces Termination of Proposed Sale of ITC
Date:7/27/2010

lve months.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec® VAD (Ventricular Assist Device) and HeartMate® LVAS (Left Ventricular Assist System) with more than 15,000 devices implanted in patients suffering from heart failure. Additionally, its ITC division is a leader in point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com or http://www.itcmed.com.

Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec Corporation. ITC, A-VOX Systems, AVOXimeter, HEMOCHRON, ProTime, ProTime InRhythm and IRMA are registered trademarks of International Technidyne Corporation.

Many of the preceding paragraphs, particularly but not exclusive to those addressing timelines for regulatory submissions and expected sale of ITC, contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements can be identified by the words, "believes," "intends," "views," "expects," "plans," "projects," "hopes," "could," "will," and other similar words. Actual results, events or performance could differ materially from these forward-looking s
'/>"/>

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Thoratec Schedules Second Quarter Conference Call, Webcast
2. Thoratec Announces Early Termination of HSR Waiting Period for the Sale of ITC to Danaher Corporation
3. Thoratec Presentation at Raymond James Conference to Be Webcast
4. Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009
5. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
6. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
7. Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
8. Thoratec Presentation at Piper Jaffray Conference to be Webcast
9. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
10. Thoratec Presentation at Canaccord Adams Conference to be Webcast
11. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 /PRNewswire/ ... report is available in its catalogue: ... U.S. IVD Industry http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html ... Care Act" (H.R. 3590) is complex legislation that ... many of its provisions are beginning to take ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportbuyer.com has added ... Defibrillators Industry https://www.reportbuyer.com/product/98394/Global-Cardiac-Defibrillators-Industry.html ... in US$ Million by the following Product Segments: Implantable/Internal ... comprehensive analytics for the US, Canada ... , Asia-Pacific , ...
(Date:8/20/2014)... , August 20, 2014 ... market report titled "Monochloroacetic Acid (MCA) Market for Cellulosics, ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... valued at USD 817.1 million in 2013 and is ... at a CAGR of 3.6% during the forecast period ...
Breaking Medicine Technology:The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Global Cardiac Defibrillators Industry 2Global Cardiac Defibrillators Industry 3Global Cardiac Defibrillators Industry 4Global Cardiac Defibrillators Industry 5Global Cardiac Defibrillators Industry 6Global Cardiac Defibrillators Industry 7Global Cardiac Defibrillators Industry 8Global Cardiac Defibrillators Industry 9Global Cardiac Defibrillators Industry 10Global Cardiac Defibrillators Industry 11Global Cardiac Defibrillators Industry 12Global Cardiac Defibrillators Industry 13Global Cardiac Defibrillators Industry 14Global Cardiac Defibrillators Industry 15Global Cardiac Defibrillators Industry 16Global Cardiac Defibrillators Industry 17Global Cardiac Defibrillators Industry 18Global Cardiac Defibrillators Industry 19Global Cardiac Defibrillators Industry 20Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4
... July 30 Peptimmune, Inc. a privately,held ... US Patent Number,7,381,790 (the ,790 patent) which ... peptide copolymer for the treatment of autoimmune ... Phase Ib multiple-ascending dose,double-blind, placebo-controlled randomized study ...
... issues a review of,Generex Biotechnology Corporation (Nasdaq: ... Platform, Sets the Tone as Best in,Class Followed ... This review is available at website: http://www.scimitarequity.com ... development, and commercialization,of drug delivery systems and technologies. ...
Cached Medicine Technology:Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 2Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 3Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC 2
(Date:8/20/2014)... An Elle Magazine online report dated August 13, 2014 ... at Every Age,” offers a set of recommendations to help ... These recommendations are offered as a preventative skincare plan. The ... beyond. The first group of recommendations can be universally applied ... sunscreen religiously, getting sufficient exercise and sleep, and eating well. ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 A new ... require a medical exam before issuing an approximate quote ... Pros company is now helping the public to obtain ... its system at http://quotespros.com/life-insurance.html . , The ... as more regulations have appeared in many U.S. states. ...
(Date:8/20/2014)... By Dennis Thompson ... -- U.S. teen birth rates fell dramatically during the past ... dollars, a new government report shows. An estimated 4 ... the decline, according to researchers from the U.S. Centers for ... "leapt out at me from the report," said Bill Albert, ...
(Date:8/20/2014)... the immune system is defective in people suffering from irritable ... ongoing issues with pain. , The research the first ... to explain why some painkillers may not offer satisfactory relief ... 10% of the community. There are different forms of ... often has the greatest impact on sufferers, quality of life. ...
(Date:8/20/2014)... 2014 (HealthDay News) -- Pigs, hearts transplanted into baboons ... as long as previously achieved, researchers report. The ... use animal organs to shorten transplant waiting lists. ... piglets into baboons, abdomens. The genetic engineering and new ... what enabled the hearts to survive for more than ...
Breaking Medicine News(10 mins):Health News:Simon Ourian, Kim Kardashian’s Doctor, On Healthy Skin Suggestions for Every Age 2Health News:Life Insurance Quotes Without Medical Exams Now Displayed to Adults at Insurance Website 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 3Health News:Pain treatments less effective for those with irritable bowel 2Health News:Pigs' Hearts Beat for a Year in Baboons' Abdomens 2
... in minimally invasive surgical techniques -- most notably, ... common surgical option across the United States for ... , A newer, third option is a hybrid ... safe and effective and compares favorably with standard ...
... Software Complies with 100% of Updated Interoperability RequirementsTAMPA, ... a leading provider of electronic health records, today ... Technology (CCHIT(R)) has approved Sage,s product, Sage Intergy ... Ambulatory EHR , additionally certified ...
... Managing Turnover According to Cejka Search and AMGA ... to the current economic crisis is that physicians ... However, with the physician shortage intensifying and ... sharpening their competitive edge in finding and keeping ...
... surgical approach to treat stomach cancer has been shown ... treatment for some patients. , A new study led ... traditional "open" surgery to remove the stomach with laparoscopic ... surgeon removes the stomach while guided by a magnified ...
... thyroid cancer is being held today at the United Nations ... of thyroid cancer among millions of people around the world ... in Ukraine on April 26, 1986. ... (NYEEI) is working in partnership with Project Chernobyl, a ...
... Therapeutics, Inc. announced today positive results from a ... evaluating fenretinide for the treatment of geographic atrophy ... analysis was triggered when all patients had reached ... http://www.newscom.com/cgi-bin/prnh/20080220/CLW064LOGO )The analysis compared the ...
Cached Medicine News:Health News:Helping hand of hybrid surgery benefits colorectal patients 2Health News:Sage Intergy EHR Receives 08 CCHIT Certification 2Health News:Sage Intergy EHR Receives 08 CCHIT Certification 3Health News:Sage Intergy EHR Receives 08 CCHIT Certification 4Health News:Sage Intergy EHR Receives 08 CCHIT Certification 5Health News:The Economy Plus Flexibility Keep Physicians in Practice 2Health News:The Economy Plus Flexibility Keep Physicians in Practice 3Health News:The Economy Plus Flexibility Keep Physicians in Practice 4Health News:New minimally invasive surgery option for patients with stomach cancer 2Health News:'Living With Radiation' Conference Commemorating Chernobyl Nuclear Disaster Held at United Nations, Sponsored by New York Eye & Ear Infirmary 2Health News:Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide 2Health News:Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide 3
Inquire...
... in laser treatment, brings remarkable results and ... EVLT is a minimally invasive, clinically proven ... and safely treats varicose veins using a ... The procedure is easy to perform and ...
... The Aculens 186 UV combines the latest ... include measurement of ultra violet transmission and ... 186 is also programmed to network with ... VELO Instruments, today, or in the future. ...
Inquire...
Medicine Products: